Search Results 91-100 of 17207 for Eosin

  1. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    About this study. The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 ...

  2. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  3. A Study to Assess Clonal Diversity of Freshly Taken ESD Specimens - Mayo Clinic

    Inclusion Criteria: Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) ...

  5. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

    Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...

  8. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    ... eosin (H&E) or IHC will be considered node-negative; any axillary lymph node with tumor clusters between 0.02 and 0.2 cm is considered a micrometastasis ...

  9. Biologic Repository for Esophageal Disease - Mayo Clinic

    The purpose of this study is to develop a Biobank of blood and tissue collected from individuals with known or suspected Barrett's esophagus , esophageal ...

  10. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Part B: To demonstrate the efficacy of dupilumab treatment compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as ...